DuPont de Nemours Inc vs Vital Farms Inc — how do they compare? DuPont de Nemours Inc trades at $144.26 (market cap $19.12B), while Vital Farms Inc trades at $11.57 (market cap $483.84M). The key difference: DuPont de Nemours Inc is far larger — about 39.5× Vital Farms Inc's market cap, and DuPont de Nemours Inc pays a 1.7% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| DD | VITL | |
|---|---|---|
Market Cap | $19.12B | $483.84M |
Sector | Basic Materials | Consumer Staples |
52-Week High | $154.59 | $52.41 |
52-Week Low | $90.24 | $8.28 |
Enterprise Value | $20.50B | $570.85M |
Dividend Yield | 1.7% | — |
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $142.48, down 1.06% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported Q2 2026 earnings that beat expectations, with EPS of $1.88 versus $1.76 expected, and raised its full-year 2026 outlook, driven by healthcare, industrial water, and aerospace demand. However, 2025 fundamentals show a net loss of $779 million on revenue of $6.85 billion, with a high P/E ratio of 61.15 indicating premium valuation.
The outlook is cautiously optimistic, supported by earnings momentum and innovation awards, but risks include ongoing legal settlements over PFAS chemicals and thin net margins. The consensus price target of $232.80 suggests significant upside potential if operational improvements continue.
Vital Farms (VITL) trades at $12.24, down 2.16% amid bearish technical signals and challenging Q2 2026 results with a net loss of $0.47 per share. Revenue declined 10.1% year-over-year to $166 million due to industry oversupply and competitive pressures. The company secured $125 million in term loan financing in August 2026 to support operations. Analyst consensus remains positive with a $13.00 price target and 56% buy ratings, though profitability metrics show significant compression with net income margin at 0.02%.
The stock faces near-term headwinds from operational challenges but maintains analyst support. Investment opportunity exists if the company can navigate industry oversupply and restore profitability. Key risks include persistent margin pressure, competitive pricing gaps, and execution of the new financing strategy. The current valuation at 11.77 P/E appears reasonable if earnings recovery materializes.
Trailing returns across standard periods
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →